v3.25.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation

For the years ended December 31, 2024, and 2023, the expected tax expense (benefit) based on the U. S. federal statutory rate is reconciled with the actual tax provision (benefit) as follows:

 

   For the Years Ended
December 31,		 
   2024   2023 
Expected tax at statutory rates  $(528,000)   21%  $(3,463,000)   21%
Permanent Differences   (4,000)   0%   7,000    0%
State Income Tax, Net of Federal benefit   1,019,000    (62)%   (418,000)   1%
Other   1,564,000    (41)%   (95,000)   2%
Current Year Change in Valuation Allowance   (2,051,000)   82%   3,969,000    (24)%
Prior Year True-Ups   -    0%   -    0%
Income tax expense  $-    0%  $-    0%
Schedule of Deferred Tax Assets and Liabilities As of December 31, 2024, and 2023, significant components of the Company’s deferred tax assets are as follows:
   As of 
   December 31,
2024		   December 31,
2023		 
Deferred Tax Assets (Liabilities):        
Accrued payroll  $141,000   $141,000 
ASC842-ROU Asset   -    - 
ASC842-ROU (Liability)   822,000    822,000 
Loss from derivatives   (869,000)   (16,000)
Waiver and commitment fee shares   -    - 
Stock based compensation   (304,000)   (171,000)
Depreciation   3,000    3,000 
Net operating loss   12,462,000    13,529,000 
Net deferred tax assets (liabilities)   12,255,000    14,308,000 
Valuation allowance   (12,255,000)   (14,308,000)
Net deferred tax assets (liabilities)  $-   $-